BWX Technologies, Inc. — Form 8-K
Filed August 3, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 48/100
What the filing says
BWX Technologies reported Q2 2026 revenues of $901.6M (up 18% YoY) and net income of $89.1M ($0.97 diluted EPS). The company closed the Precision Components Group acquisition on July 1, 2026 (purchase price not disclosed in filing), announced a medical business divestiture to focus on nuclear defense/power markets, and raised full-year guidance: adjusted EBITDA to $662–$672M (from $650–$665M), non-GAAP EPS to $4.70–$4.80 (from $4.60–$4.75), and free cash flow to $345–$360M (from $315–$330M).
Why this rating
Guidance raise and PCG acquisition support growth trajectory. Medical divestiture strategically refocuses portfolio. Combined moves material but modest relative to $13.2B market cap; organic growth drivers and cash generation remain core strengths.
Extracted items
- 2.02 results / earnings
- 9.01 exhibits
See more from August 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.